Search
    Skip to main content
    Advertisement

    Merck and Co

    1. Business
    2. Pharmaceuticals
    3. Merck and Co
    Can Merck's new drugs & pipeline ease Keytruda loe concerns? Zacks11:13Keytruda Pharma
    Merck's Keytruda Drives its 2025 Revenue Surge: What's Ahead? Zacks11:14Keytruda Pharma
    Merck (MRK) rises higher than market: Key facts Zacks18:45S&P 500 Dow Jones Nasdaq
    Merck (MRK) stock dips while market gains: Key facts Zacks18:46S&P 500 Dow Jones Nasdaq
    Merck Healthcare Korea launches dosing management platform for Saizen therapy Korea Biomedical Review03:26Merck Healthcare Korea Pharma Hormone Replacement Therapy
    Merck Healthcare Korea marks ‘Give To Gain’ commitment in celebration of International Women’s Day Korea Biomedical Review02:01Merck Healthcare Korea Pharma Hormone Replacement Therapy
    AI-Powered tempus inks new multi-year Merck deal Benzinga14:39AI NYSE Stock Markets
    Union Minister Ashwini Vaishnaw meets Merck Electronics EVP Katherine Dei Cas, discusses… AniNews.in12:50Northern Territory Indian Politics Pharma
    Merck animal Health awards $50,000 in scholarships to five next generation swine veterinarians AgriMarketing03:03New Jersey Business Business (US) Pharma
    Merck cuts staff at Gardasil plant amid slump in global demand Bloomberg Law12:52Pharma Health

    Latest News

    Earlier today
    Can Merck's New Drugs & Pipeline Ease Keytruda LOE Concerns? Zacks11:13
    Merck Highlights New Data from Cardio-Pulmonary Pipeline at ACC.26 Showcasing Commitment to… Business Wire (Press Release)08:02
    In the last 7 days
    Merck signs MoU with Cyto-Facto to advance Cell & Gene Therapy manufacturing in APAC region BioSpectrum Asia07:49 11-Mar-26
    Merck (MRK) Rises Higher Than Market: Key Facts Zacks18:45 9-Mar-26
    Neuroendocrine Carcinoma Market Poised for Significant Growth During the Forecast Period… PR Newswire (Press Release)17:36 9-Mar-26
    Merck Healthcare Korea launches dosing management platform for Saizen therapy Korea Biomedical Review03:26 9-Mar-26
    In the last month
    2. Bundesliga preview: SV Darmstadt vs. Holstein Kiel Bulinews08:15 6-Mar-26
    Merck Healthcare Korea marks ‘Give To Gain’ commitment in celebration of International Women’s Day Korea Biomedical Review02:01 6-Mar-26
    Merck Group views China as an opportunity for partnership People's Daily20:50 5-Mar-26
    Merck (MRK) Up 1.7% Since Last Earnings Report: Can It Continue? Zacks12:43 5-Mar-26
    After generic defense fails, Merck KGaA assumes no US Mavenclad sales after March FiercePharma11:47 5-Mar-26
    Are Investors Undervaluing Merck KGaA (MKKGY) Right Now? Zacks10:41 5-Mar-26
    Merck: Guidance for 2025 Delivered, Growth Foundation in Place Merck Group (Press Release)09:00 5-Mar-26
    Generic competition and forex headwinds to hit earnings at Merck ShareCast08:29 5-Mar-26
    Merck KGaA (MKKGY) Lags Q4 Earnings Estimates Zacks08:07 5-Mar-26
    DAX Up Slightly; Deutsche Post, Merck Down On Weak Updates RTT News05:16 5-Mar-26
    Merck Animal Health Awards $50,000 In Scholarships To Five Next Generation Swine Veterinarians AgriMarketing03:03 5-Mar-26
    Cas and effect: Merck’s phase III ripples Hif-2α space BioWorld17:00 3-Mar-26
    AI-Powered Tempus Inks New Multi-Year Merck Deal Benzinga14:39 3-Mar-26
    Merck’s Oncology Results And Tempus AI Deal Reframe Post Keytruda Future Simply Wall St14:09 3-Mar-26
    Merck's Keytruda Drives its 2025 Revenue Surge: What's Ahead? Zacks11:14 3-Mar-26
    Tempus Announces Strategic Collaboration Agreement with Merck to Accelerate AI-Driven Precision … Business Wire (Press Release)08:31 3-Mar-26
    Merck (MRK) Stock Dips While Market Gains: Key Facts Zacks18:46 2-Mar-26
    Biliary Tract Cancer Market is Predicted to Exhibit Remarkable Growth at a CAGR of 10.1% During … PR Newswire (Press Release)17:33 2-Mar-26
    Is It Worth Investing in Merck (MRK) Based on Wall Street's Bullish Views? Zacks10:38 2-Mar-26
    STAT Plus: A Merck cancer drug to watch STAT09:49 2-Mar-26
    Pulmonary hypertension after Winrevair: where GSK’s $950M bet fits Labiotech09:09 2-Mar-26
    WELIREG(R) (belzutifan) Plus LENVIMA(R) (lenvatinib) Reduced the Risk of Disease Progression or … JCN Newswire00:08 2-Mar-26
    A new standard? Merck's Welireg combos deliver 1-2 punch to kidney cancer FiercePharma10:12 28-Feb-26
    Top DAX Index shares to watch next week: Bayer, Adidas, Merck, Lufthansa Invezz22:29 27-Feb-26
    Merck to wind down Gardasil production at N.C. plant, lay off 150-plus FiercePharma15:02 27-Feb-26
    Merck to end HPV vaccine production in Durham, laying off 154 workers News & Observer, North Carolina14:17 27-Feb-26
    Merck Cuts Staff at Gardasil Plant Amid Slump in Global Demand Bloomberg Law12:52 27-Feb-26
    Merck (MRK) Valuation Check As Keytruda Patent Risk Drives Major Human Health Restructuring Simply Wall St00:17 26-Feb-26
    Merck Touts Doravirine/Islatravir’s Non-INSTI Advantage Scrip Pharma Intelligence16:18 25-Feb-26
    Here is What to Know Beyond Why Merck & Co., Inc. (MRK) is a Trending Stock Zacks10:09 25-Feb-26
    Vaishnaw, Merck discuss expanding role in India semiconductor ecosystem The Hindu Business Line21:11 24-Feb-26
    Merck & Co to create a separate cancer unit as patent cliff looms The Times of India13:36 24-Feb-26
    Union Minister Ashwini Vaishnaw meets Merck Electronics EVP Katherine Dei Cas, discusses… AniNews.in12:50 24-Feb-26
    How Is Merck & Co.'s Stock Performance Compared to Other Healthcare Stocks? Barchart11:10 24-Feb-26
    Merck to Participate in the TD Cowen 46th Annual Health Care Conference Business Wire (Press Release)06:46 24-Feb-26
    Merck & Co. New Business Structure To Support Diversifying Portfolio Scrip Pharma Intelligence15:48 23-Feb-26
    Merck Restructures Human Health To Highlight Oncology And Post Keytruda Growth Simply Wall St15:19 23-Feb-26
    Girding against Keytruda cliff, Merck splits oncology into standalone business unit FiercePharma10:27 23-Feb-26
    Merck's Strategic Shift Signals New Growth Horizons Benzinga09:19 23-Feb-26
    Merck creates separate oncology arm ahead of Keytruda patent loss Invezz09:19 23-Feb-26
    Merck reportedly ready to the splits as Keytruda patent cliff looms. Market shrugs Proactive Investors (UK)08:28 23-Feb-26
    Merck & Co to spin off cancer unit ahead of Keytruda patent cliff ShareCast07:28 23-Feb-26
    Merck Evolves Human Health Operating Structure to Support Portfolio Execution Business Wire (Press Release)06:48 23-Feb-26
    Merck Creating Cancer Unit as Patent Cliff Looms, WSJ Says (1) Bloomberg Law06:32 23-Feb-26
    Materials innovation key to keeping up with chip progress, says Merck EVP The Korea Times20:49 22-Feb-26
    Merck: This Cancer‑Drug Powerhouse Could Be a Core Dividend Holding for Decades The Motley Fool16:26 22-Feb-26
    Could Merck Stock Quietly Help Turn Steady Dividends Into a Millionaire Retirement? The Motley Fool11:20 22-Feb-26
    Merck Wants Out Of Ex-Workers' Wage, ADA Suit Law36018:21 20-Feb-26
    Merck vs. Bristol Myers: Which Pharma Stock Is a Better Pick in 2026? Zacks13:12 20-Feb-26
    Merck Animal Health Highlights Bovine Respiratory Disease Solutions For Cattle Producers Southeast AgNet10:16 20-Feb-26
    [Global Pharma Leadership Voices] The future of Korea that even Elon Musk is worried about Korea Biomedical Review20:00 19-Feb-26
    Merck und Mayo Clinic bündeln Kräfte für KI-gestützte Arzneimittelforschung und Präzisionsmedizin Newswise (Press Release)13:36 19-Feb-26
    Executives On The Move: Interim CEO Takes Helm At Sanofi Ahead Of New Chief from Merck KGaA Scrip Pharma Intelligence12:33 19-Feb-26
    Merck to seek 2nd-season RSV nod for Enflonsia in hot pursuit of Sanofi, AZ's Beyfortus FiercePharma10:46 19-Feb-26
    Merck e Mayo Clinic anunciam nova colaboração em pesquisa e desenvolvimento para impulsionar descoberta de medicamentos … Newswise (Press Release)09:52 19-Feb-26
    Merck y Mayo Clinic anuncian una nueva colaboración en investigación y desarrollo para impulsar el descubrimiento de… Newswise (Press Release)09:52 19-Feb-26
    Merck Discloses Positive Data For Respiratory Syncytial Virus Antibody Treatment, Seeks FDA Nod For Broader Child Use Benzinga08:06 19-Feb-26
    Merck Announces Positive New Data for Enflonsia™ (clesrovimab) for Infants and Children Under 2 … Business Wire (Press Release)05:20 19-Feb-26
    MSD and Mayo Clinic team up to advance AI in drug development Hospital Management05:18 19-Feb-26
    Merck Inks AI Drug Discovery Deal With Mayo Clinic To Revolutionize Drug Discovery Benzinga13:11 18-Feb-26
    Merck stock forecast: Third-party price targets Capital Com09:21 18-Feb-26
    Merck and Mayo Clinic Announce New Research and Development Collaboration to Support AI-Enabled … Business Wire (Press Release)06:46 18-Feb-26
    New Leadership for the Merck Family Foundation Merck Group (Press Release)05:03 18-Feb-26
    Chip complexity to fuel materials surge, says Merck Korea chief The Korea Herald00:17 18-Feb-26
    Merck Animal Health Highlights SAFE-GUARD® Deworming Options for Cattle Producers Southeast AgNet16:50 16-Feb-26
    Merck Indicates Better Growth Visibility in Post-Keytruda LOE Period Zacks12:54 16-Feb-26
    New topical Exzolt Cattle‑CA1 offers prevention and treatment options for New World screwworm Brownfield Ag News11:40 16-Feb-26
    Merck Foundation Chief Executive Officer (CEO), Rasha Kelej underscore their commitment to… African Press Organization04:43 16-Feb-26
    Evaluating Merck KGaA (XTRA:MRK) After Sphingolipids Growth Outlook Fuels Fresh Investor Interest Simply Wall St20:10 14-Feb-26
    view more headlines
    16 Mar 11:13

    Merck & Co News

    NewsNow aims to be the world's most accurate and comprehensive aggregator of Merck & Co news, covering the latest MSD share price, Merck Sharp & Dohme company announcements, product trials, pharmaceutical news and more from the best online publications. Every story from every site is brought to you automatically and continuously 24/7, within around 10 minutes of publication.
    Read more

    Pharmaceuticals Top Stories

    Cogent biosciences stock climbs after FDA accepts key Drug application Benzinga12:42
    AI is reviving tech sectors that VCs had all but forgotten Fortune11:44
    Six biotech companies advancing the next generation of prostate cancer therapies Labiotech10:44
    Pipeline Watch: Six Approvals And Ten Phase III Readouts Scrip Pharma Intelligence10:37
    AstraZeneca’s Imfinzi approved in EU for early gastric and gastro-oesophageal cancers PMLiVE08:30

    Business Top Stories

    This artificial intelligence (AI) stock has a $19.4 Billion Microsoft deal, a $3 billion Meta deal, and now a $2… The Motley Fool19:50Nvidia AI IT
    Meta's $27B AI cloud deal sends Nebius Group stock soaring Investopedia18:03Nvidia AI IT
    Stock market today, march 16: Nvidia rises after GTC 2026 unveils new Blackwell and Vera Rubin AI architectures The Motley Fool17:28Nvidia Top Tech Brands AI
    Nvidia investors just got incredible news from CEO Jensen Huang: 2 Highlights from GTC The Motley Fool18:28Nvidia Top Tech Brands AI
    From AI mega-spend to tax cash flood—Nasdaq's hidden tailwinds Barchart16:42SpaceX Nasdaq Stock Markets
    SpaceX could IPO in June at a $1.75 Trillion valuation. Here is 1 stock to buy before it does. The Motley Fool18:28SpaceX Nasdaq Stock Markets
    Prediction: This Artificial Intelligence (AI) stock will skyrocket after march 18 (hint: It's not Micron) The Motley Fool16:27Micron AI IT
    Prediction: Micron Technology stock will soar higher after march 18 The Motley Fool14:04Micron AI IT
    Cruise lines face fuel cost surge as oil prices jump on Iran tensions Fox News18:33Iranian Oil Energy Energy and Utilities
    US cruises sail into higher costs as oil prices rally; Carnival could be hardest hit gCaptain08:45Iranian Oil Energy Energy and Utilities
    Publication filters

    Headline Density

    Sorry, no headlines or news topics were found. Please try different keywords.